DLCLHealthcare Service Provider
Dr Lalchandani Labs Ltd — Profit & Loss Statement
₹14.81
+0.00%
Dr Lalchandani Labs Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.04 Cr | 0.00 | 0.00 | -41226.98 | — |
| Tax Rate For Calcs | 0.30 | 0.00 | 0.00 | 0.27 | — |
| Normalized EBITDA | 0.93 Cr | 0.44 Cr | 0.12 Cr | 2.44 Cr | — |
| Total Unusual Items | 0.12 Cr | 1.19 Cr | -0.13 Cr | -0.01 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.12 Cr | 1.19 Cr | -0.13 Cr | -0.01 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 0.42 Cr | 0.62 Cr | -1.56 Cr | 0.93 Cr | — |
| Reconciled Depreciation | 0.56 Cr | 0.62 Cr | 0.66 Cr | 0.59 Cr | — |
| Reconciled Cost Of Revenue | 0.96 Cr | 2.05 Cr | 1.21 Cr | 2.98 Cr | — |
| EBITDA | 1.05 Cr | 1.63 Cr | -0.02 Cr | 2.42 Cr | — |
| EBIT | 0.49 Cr | 1.00 Cr | -0.68 Cr | 1.83 Cr | — |
| Net Interest Income | -0.09 Cr | -0.38 Cr | -0.99 Cr | -0.60 Cr | — |
| Interest Expense | 0.09 Cr | 0.38 Cr | 0.88 Cr | 0.55 Cr | — |
| Normalized Income | 0.33 Cr | -0.57 Cr | -1.43 Cr | 0.94 Cr | — |
| Net Income From Continuing And Discontinued Operation | 0.42 Cr | 0.62 Cr | -1.56 Cr | 0.93 Cr | — |
| Total Expenses | 4.09 Cr | 5.23 Cr | 5.48 Cr | 9.38 Cr | — |
| Diluted NI Availto Com Stockholders | 0.42 Cr | 0.62 Cr | -1.56 Cr | 0.93 Cr | — |
| Net Income Common Stockholders | 0.42 Cr | 0.62 Cr | -1.56 Cr | 0.93 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 0.42 Cr | 0.62 Cr | -1.56 Cr | 0.93 Cr | — |
| Net Income Including Noncontrolling Interests | 0.42 Cr | 0.62 Cr | -1.56 Cr | 0.93 Cr | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 0.42 Cr | 0.62 Cr | -1.56 Cr | 0.93 Cr | — |
| Tax Provision | -0.01 Cr | 0.00 | 0.00 | 0.35 Cr | — |
| Pretax Income | 0.40 Cr | 0.62 Cr | -1.56 Cr | 1.29 Cr | — |
| Other Non Operating Income Expenses | 74000.00 | 0.24 Cr | 49000.00 | 8000.00 | — |
| Special Income Charges | 0.12 Cr | 1.19 Cr | -0.13 Cr | -0.01 Cr | — |
| Other Special Charges | -0.12 Cr | -1.34 Cr | — | 0.01 Cr | 92000.00 |
| Net Non Operating Interest Income Expense | -0.09 Cr | -0.38 Cr | -0.99 Cr | -0.60 Cr | — |
| Interest Expense Non Operating | 0.09 Cr | 0.38 Cr | 0.88 Cr | 0.55 Cr | — |
| Operating Income | 0.36 Cr | -0.42 Cr | -0.44 Cr | 1.90 Cr | — |
| Operating Expense | 3.14 Cr | 3.18 Cr | 4.27 Cr | 6.40 Cr | — |
| Other Operating Expenses | 1.75 Cr | 1.49 Cr | 1.20 Cr | 2.12 Cr | — |
| Depreciation And Amortization In Income Statement | 0.56 Cr | 0.62 Cr | 0.66 Cr | 0.59 Cr | — |
| Depreciation Income Statement | 0.56 Cr | 0.62 Cr | 0.59 Cr | 0.51 Cr | — |
| Gross Profit | 3.50 Cr | 2.75 Cr | 3.83 Cr | 8.30 Cr | — |
| Cost Of Revenue | 0.96 Cr | 2.05 Cr | 1.21 Cr | 2.98 Cr | — |
| Total Revenue | 4.45 Cr | 4.81 Cr | 5.04 Cr | 11.28 Cr | — |
| Operating Revenue | 4.45 Cr | 4.81 Cr | 5.04 Cr | 11.28 Cr | — |
| Interest Income | — | 0.02 Cr | 49000.00 | 8000.00 | 0.00 |
| Rent Expense Supplemental | — | 0.29 Cr | 0.56 Cr | 1.41 Cr | 0.79 Cr |
| Diluted Average Shares | — | 0.43 Cr | 0.43 Cr | 0.43 Cr | 0.43 Cr |
| Basic Average Shares | — | 0.43 Cr | 0.43 Cr | 0.43 Cr | 0.43 Cr |
| Diluted EPS | — | 1.43 | -3.61 | 2.15 | 2.33 |
| Basic EPS | — | 1.43 | -3.61 | 2.15 | 2.33 |
| Write Off | — | 0.29 Cr | 0.13 Cr | 0.00 | 0.00 |
| Impairment Of Capital Assets | — | 23000.00 | 11000.00 | — | — |
| Total Other Finance Cost | — | 0.02 Cr | 0.11 Cr | 0.05 Cr | 0.15 Cr |
| Interest Income Non Operating | — | 0.02 Cr | 49000.00 | 8000.00 | 0.00 |
| Amortization | — | 0.07 Cr | 0.07 Cr | 0.08 Cr | 0.04 Cr |
| Selling General And Administration | — | 0.19 Cr | 0.38 Cr | 0.82 Cr | 0.52 Cr |
| Selling And Marketing Expense | — | 0.03 Cr | 0.13 Cr | 0.11 Cr | 0.03 Cr |
| General And Administrative Expense | — | 0.16 Cr | 0.25 Cr | 0.71 Cr | 0.49 Cr |
| Rent And Landing Fees | — | 0.29 Cr | 0.56 Cr | 1.41 Cr | 0.79 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Dr Lalchandani Labs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.